rs1883723
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_024411.5(PDYN):c.-20+4387A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.121 in 152,088 control chromosomes in the GnomAD database, including 1,215 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.12 ( 1215 hom., cov: 32)
Consequence
PDYN
NM_024411.5 intron
NM_024411.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.00900
Publications
1 publications found
Genes affected
PDYN (HGNC:8820): (prodynorphin) The protein encoded by this gene is a preproprotein that is proteolytically processed to form the secreted opioid peptides beta-neoendorphin, dynorphin, leu-enkephalin, rimorphin, and leumorphin. These peptides are ligands for the kappa-type of opioid receptor. Dynorphin is involved in modulating responses to several psychoactive substances, including cocaine. Multiple alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2010]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.19 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.121 AC: 18317AN: 151970Hom.: 1211 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
18317
AN:
151970
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.121 AC: 18339AN: 152088Hom.: 1215 Cov.: 32 AF XY: 0.121 AC XY: 9007AN XY: 74352 show subpopulations
GnomAD4 genome
AF:
AC:
18339
AN:
152088
Hom.:
Cov.:
32
AF XY:
AC XY:
9007
AN XY:
74352
show subpopulations
African (AFR)
AF:
AC:
6957
AN:
41448
American (AMR)
AF:
AC:
1235
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
259
AN:
3468
East Asian (EAS)
AF:
AC:
1029
AN:
5154
South Asian (SAS)
AF:
AC:
652
AN:
4810
European-Finnish (FIN)
AF:
AC:
1404
AN:
10590
Middle Eastern (MID)
AF:
AC:
26
AN:
294
European-Non Finnish (NFE)
AF:
AC:
6420
AN:
68000
Other (OTH)
AF:
AC:
220
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
798
1596
2395
3193
3991
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
779
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.